# Sanofi relocates production of type 1 diabetes treatment to Lyon

> Sanofi has transferred to France, at its Lyon Gerland site, the production of a biotherapy for type 1 diabetes acquired from the United States in 2023. The group presents this relocation as a commitment to health sovereignty.

**In brief**: Economy event (severity: notable) in Lyon Gerland (Rhône), first detected on 17 November 2026 at 19:00. Reported by 1 source (1 article), last updated on 17 November 2026 at 19:00.

- Category: Economy
- Severity: Notable
- Place: Lyon Gerland — Rhône
- First detected: 17 November 2026 at 19:00
- Updated: 17 November 2026 at 19:00
- Web page: https://acturadar.com/en/events/23228-sanofi-relocates-production-of-type-1-diabetes-treatment-to-lyon

## Sources (1 articles)

- [Santé. Comment Sanofi a relocalisé un médicament contre le diabète à Lyon](https://www.leprogres.fr/economie/2026/11/17/comment-sanofi-a-relocalise-un-medicament-contre-le-diabete-a-lyon) — Le Progrès, 17 November 2026 at 19:00

---

Cite as: Acturadar, “Sanofi relocates production of type 1 diabetes treatment to Lyon”, https://acturadar.com/en/events/23228-sanofi-relocates-production-of-type-1-diabetes-treatment-to-lyon
Methodology: https://acturadar.com/en/methodology
